Skip to content
ApprovedFDA approvedATC · C10AA05Rx · Prescription only (Rx)

Atorvastatin

Prescription cholesterol-lowering medicine (a statin) that also lowers the risk of heart attack and stroke.

Atorvastatin vial

Related comparisons

Atorvastatin vs Rosuvastatin

DETAILED OVERVIEW

What is Atorvastatin?

Atorvastatin is a prescription cholesterol-lowering medicine from the statin group. It is used for high cholesterol and to prevent heart attack and stroke, for example in people who have already had one, and in people with diabetes.

It blocks cholesterol production in the liver, so the liver removes more LDL (“bad” cholesterol) from the blood, and LDL can fall by 30–60%. Large studies show that this lowers the risk of heart attack, stroke and death from heart and blood vessel disease. Muscle pain and weakness can occur; rarely a severe muscle injury develops that can lead to kidney failure, more likely with strong drug interactions or regular grapefruit juice. It can raise liver enzymes and slightly raises the chance of developing diabetes. It must not be used in pregnancy or breastfeeding, because cholesterol is needed for the baby's development.

ATC code

C10AA05

Prescription

Prescription only (Rx)

Mechanism

HMG-CoA reductase inhibitor (statin)

Half-life

14 h (active metabolites 20-30 h)

LDL reduction

50–60% with the strongest form of treatment

Data console

Lab data

ATC codeC10AA05
PrescriptionPrescription only (Rx)
MechanismAtorvastatin blocks an enzyme in liver cells called…
Half-life14 h (parent), 20-30 h (active ortho- and para-hydroxylated metabolites)
Onset1-2 weeks (lipid lowering), 4-6 weeks (steady-state LDL effect)
Bioavailability~14% (oral, presystemic clearance + first-pass metabolism – FDA Lipitor label)

Safety

Side effects, stop signs, contraindications

Side effects · 7

  • Muscle pain, myalgia and weakness (statin-associated muscle symptoms, SAMS), typically symmetric and proximal; dose-dependent, more common at 80 mg.
  • Rare but serious: rhabdomyolysis (CK >10x ULN + myoglobinuria) that can cause acute kidney injury; risk increased when combined with CYP3A4 inhibitors or fibrates.
  • Elevation of liver transaminases (ALT/AST), usually reversible and dose-dependent; persistent rise >3x ULN warrants dose reduction or discontinuation.
  • Slightly increased risk of new-onset type 2 diabetes (about 9–12% relative), mainly in prediabetic patients; cardiovascular benefit outweighs this.
  • Gastrointestinal complaints: nausea, diarrhea, constipation, abdominal discomfort, dyspepsia.
  • Headache, nasopharyngitis, joint pain (arthralgia) and pain in extremities, among the common, generally mild adverse effects.
  • Very rare: immune-mediated necrotizing myopathy (anti-HMGCR antibodies), which can persist after stopping the statin and requires immunosuppression.

Contraindications · 4

  • Active liver disease or persistent unexplained ALT elevation (>3x ULN)
  • Pregnancy and lactation (lipid synthesis needed for embryonic development)
  • Concomitant strong CYP3A4 inhibitor use (clarithromycin, itraconazole, ritonavir)
  • Active rhabdomyolysis or CK elevation > 10x ULN

Related Pharmaceuticals

Same therapeutic category

Studies

Related research and clinical findings

Telegram

Have a question about Atorvastatin?

Educational drug info from official sources (PubMed, FDA, EMA). Does NOT replace medical consultation or the SmPC. Talk to your doctor!

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is for educational and scientific purposes only. Medication use requires medical consultation and a prescription. The indications, dose ranges, and side effects listed here do NOT replace the official Summary of Product Characteristics (SmPC) or consultation with a physician. Do not start or stop any medication on your own. In an emergency, call your local emergency number.